LIFE-U:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund (USD)

ETF | Others |

Last Closing

CAD 18.22

Change

0.00 (0.00)%

Market Cap

N/A

Volume

2.50K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

-0.46 (-1.46%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.22 (-0.78%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

+0.67 (+2.62%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.92 (-2.75%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.40 (-0.87%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.70 (+2.39%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.05 (+0.46%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.15 (-0.64%)

CAD 2.78B

ETFs Containing LIFE-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.05% 52% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.05% 51% F 47% F
Trailing 12 Months  
Capital Gain -10.73% 9% A- 18% F
Dividend Return 1.72% 43% F 29% F
Total Return -9.01% 9% A- 17% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -2.03% 12% F 19% F
Dividend Return -1.66% 10% F 13% F
Total Return 0.37% 42% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 5.99% 75% C 88% B+
Risk Adjusted Return -27.80% 10% F 10% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.